Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $41.18 USD
Change Today -0.85 / -2.02%
Volume 231.0K
ENTA On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert Kamen Ph.D.

AgeTotal Calculated CompensationThis person is connected to 46 board members in 4 different organizations across 9 different industries.

See Board Relationships
----

Background*

Dr. Robert Kamen, Ph.D., also known as Bob, is a Co-Founder of BioAssets Development Corporation and serves as its Chief Scientific Officer. Dr. Kamen is an Entrepreneur-in-Residence of Third Rock Ventures, LLC and has been its Consultant since 2010. At the firm, he focuses on the formation and development of biologics companies that develop life-changing therapies for patients. Dr. Kamen is a Consultant to the biotech and pharmaceutical industry. He serves as Business ...

Read Full Background

Corporate Headquarters*

500 Arsenal Street
Watertown, Massachusetts 02472

United States

Phone: 617-607-0800
Fax: 617-607-0530

Board Members Memberships*

Director

Education*

PhD
Harvard University
Bachelor's Degree
Amherst College
BS
Amherst College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENTA:US $41.18 USD -0.85

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENANTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.